Your browser doesn't support javascript.
loading
Prevalence, Incidence and Factors Associated with Diabetic Foot in People with Type 2 Diabetes: Systematic Review with Meta-Analysis.
de Jesus Nascimento de Aquino, Maria; de Souza, Ana Célia Caetano; Borges, José Wicto Pereira; da Silva Negreiros, Francisca Diana; de Sousa Gonçalves, Marilia; Martins, Polyanna Maria Oliveira; Moreira, Thereza Maria Magalhães.
Afiliación
  • de Jesus Nascimento de Aquino M; Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, Rodolfo Teófilo, Fortaleza, Ceará, 60430-372, Brazil.
  • de Souza ACC; Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, Rodolfo Teófilo, Fortaleza, Ceará, 60430-372, Brazil.
  • Borges JWP; Department of Nursing, Federal University of Piauí, Teresina, Brazil.
  • da Silva Negreiros FD; Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, Rodolfo Teófilo, Fortaleza, Ceará, 60430-372, Brazil.
  • de Sousa Gonçalves M; Department of Nursing, Centro Universitário UNINTA, Sobral, Brazil.
  • Martins PMO; Department of Nursing, Federal University of Piauí, Teresina, Brazil.
  • Moreira TMM; Clinical Care in Nursing and Health Gradutate Program, Universidade Estadual do Ceará, Fortaleza, Brazil.
Curr Diabetes Rev ; 20(1): e070423215527, 2024.
Article en En | MEDLINE | ID: mdl-37026500
BACKGROUND: Diabetic Foot is a severe chronic complication of diabetes and an important factor in the morbidity of diabetic people, resulting in high health costs and increased risk of death. OBJECTIVE: To analyze the incidence, prevalence, and risk factors associated with diabetic foot in people with type 2 Diabetes Mellitus. METHOD: Systematic literature review. Searches in MedLine via PubMed, LILACS, Web of Science, Scopus CINAHL, and Cochrane Library databases were performed. Inclusion of 52 studies. The R program, Metan packages, was used to calculate the meta-analysis. Given the heterogeneity of studies, the random effect was used to calculate the meta-analysis of risk factors. RESULTS: The meta-analysis showed that the prevalence of diabetic foot was 14% in a hospital setting and 5% in a community setting. The overall prevalence and incidence were 9% and 4%, respectively. Significant risk factors included time of DM (odds ratio [OR] =1.46, confidence interval [CI], 0.36-2.57, P = 0.009), smoking (OR = 1.46, CI, 1.16 -1.85, P< .001), glycated hemoglobin (OR = 0.96, CI, 0.50; 1.42, P< .001), peripheral arterial disease (OR = 3.38, CI, 2.07; 5.53, P < .001) and peripheral neuropathy (OR = 5.88, CI, 2.39-14.45, P<.001). CONCLUSION: Multidisciplinary monitoring, educational strategies, periodic foot examination for alterations, and early identification of risk factors are essential to prevent ulceration and reduce the disease burden.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pie Diabético / Diabetes Mellitus Tipo 2 Tipo de estudio: Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Curr Diabetes Rev Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Emiratos Árabes Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pie Diabético / Diabetes Mellitus Tipo 2 Tipo de estudio: Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Curr Diabetes Rev Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Emiratos Árabes Unidos